specialty drugs

Ten ways hospitals can manage rising drug costs
Ten ways hospitals can manage rising drug costsFluctuations in drug pricing and medication shortages are among the reasons for rising drug prices. Learn how you can protect your hospital’s bottom line.
Payers can predict budget implications of high-cost drugs in the pipelineA University of Massachusetts clinical consulting pharmacist shows how assessing budget implications can be accomplished.
Specialty drug pipeline predictions: Seven key areas to watchThe specialty drugs market will see more approvals in 2017 than 2016. Top areas to watch include cancer, multiple sclerosis, and HIV.
Pharmacists Help Boost Adherence RatesVanderbilt Specialty Pharmacy has created a model to integrate its pharmacists into its specialty clinics.
Oral specialty drug options on the horizon
Oral specialty drug options on the horizonAs more specialty drugs are approved, cost control strategies are key.
Specialty Drugs: Unintended Consequences May Slow the Market
Specialty Drugs: Unintended Consequences May Slow the MarketReport looks at possible impediments to growth in the specialty market, including patient access.
Top 5 specialty drug management issuesThe 13th edition EMD Serono Specialty Digest outlines top specialty drug management issues health plans face.
Opinion: Top 2 takeaways from Asembia Specialty Pharmacy SummitThe conference raised important points about value-based contracts and the specialty pharmacy space.
Why Specialty Drug Prices Will Continue to Soar
Why Specialty Drug Prices Will Continue to SoarSpecialty drugs will dominate the future of pharmaceuticals.
What’s in the Specialty Pharmacy Pipeline?
What’s in the Specialty Pharmacy Pipeline?Biosimilars, cancer drugs, and orphan drugs are heading towards FDA approval in 2017.